FATE THERAPEUTICS INC FATE 32.7
Health Care · NASDAQ · Data as of 2026-08-13
FATE THERAPEUTICS INC (FATE) has delivered +21.6% annualized revenue growth, n/a earnings growth, and n/a dividend growth over 10 years of data. Ranked #1763 of 1968 stocks overall and #225 of 260 in the Health Care sector by Steady Score.
Industry
Biological Products
Steady Score
32.7
Overall Rank
#1763 / 1968
Sector Rank
#225 / 260
Revenue CAGR
+21.6%
Earnings CAGR
-
Dividend CAGR
-
?
E/R CAGR Ratio
-
Revenue
Earnings
Dividends
Free Cash Flow
Margin
NET Margin
FCF Margin
Payout Ratio
Payout Ratio
FCF Payout Ratio